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Objective: The aim of this study was to evaluate the effects of the mixture of branched-chain amino
acids (BCAAs) supplementation compared with leucine administered orally on muscle biochemical
parameters of trained rats submitted to an exercise-induced protocol of glycogen depletion.
Methods: After 6 wk of swimming exercise, 8 wk-old (250 g, adult) male Wistar rats were randomly
divided into three experimental groups (n ¼ 8 per group): the mixture of BCAAs (BCAAs), leucine
(LEU), and placebo (PLA). All groups were submitted to swimming exercise for 6 wk and supple-
mented with either the mixture of BCAAs, leucine, or placebo during the last week of training. At
week 7 of the protocol, the rats were submitted to an intermittent, progressive swimming test until
exhaustion and sacriﬁced. Muscle gastrocnemius and liver were depicted to determine total
glycogen, tricarboxylic acid cycle (TCA) intermediates, and enzymatic activities. Statistical evalu-
ation was performed by one-way analysis of variance with Tukey post hoc test.
Results: Both muscle and liver glycogen degradation ratio were signiﬁcantly higher in the mixture
of BCAAs group compared to the PLA group (P < 0.05) and the LEU group presented decreased liver
glycogen degradation ratio compared with the mixture of BCAAs group (P < 0.05). Both muscle and
liver glycogen content were signiﬁcantly spared in the mixture of BCAAs and LEU groups compared
to the PLA group (P < 0.01). A performance test demonstrated that LEU supplementation enhanced
resistance to exhaustion compared to the mixture of BCAAs (P < 0.001), however, no difference
was found when LEU supplementation was compared to PLA (P > 0.05) Muscle citrate content was
signiﬁcantly higher in the mixture of BCAAs group compared with the PLA group (P < 0.001).
Muscle malate content was signiﬁcantly elevated in the mixture of BCAAs group compared with
both the PLA (P < 0.001) and LEU groups (P < 0.001). BCAT activity was signiﬁcantly reduced in the
mixture of BCAAs supplementation group compared with the LEU group (P < 0.001).
Conclusion: Leucine supplementation improved performance compared with the mixture of BCAAs
supplementation, sparing muscle glycogen stores despite the augmentation of some TCA inter-
mediate concentrations on the left side of the TCA cycle.
 2013 Elsevier Inc. All rights reserved.Introduction Glucose is an important fuel for exercising muscles; the lack ofSince the studies of Bergstrom and Hultman in 1960s [1,2],
the relationship between skeletal muscle glycogen content and
the capacity for exercise (i.e., muscle fatigue) is well known. The
regulation of carbohydrate provision during prolonged exercise
and recovery is a profound challenge for the human body.t.
x: þ55 11 3091 3136.
rraz).
ll rights reserved.carbohydrate reserves in liver result in reduced pyruvate levels,
a substrate for both acetyl-coenzyme A (acetyl-CoA) formation
and for anaplerotic reactions, which are necessary for continuous
oxidation of free fatty acids and amino acids [3]. However,
muscle carbohydrate metabolism does not happen in isolation
but requires integration across tissues as well as regulation with
the other major substrates, such as fats and amino acids [4,5].
In this context, the supplementation of amino acids, espe-
cially the glucogenic types, may play an important role (e.g., the
increase in muscle alanine production during exercise and the
Fig. 1. Leucine is transaminated to alanine in skeletal muscle. Alanine reaches the
liver where it can be reconverted to glucose. Simultaneously, leucine can augment
translocation of GLUT-4 in a situation of low energy availability or stimulate insulin
secretion and consequently glucose uptake and protein synthesis when energy
supply is adequate.
P. L. Campos-Ferraz et al. / Nutrition 29 (2013) 1388–1394 1389increased liberation of alanine in the bloodstream result in its
higher contribution to glucose synthesis in liver) [6,7], thus, the
mixture of BCAAs (isoleucine, leucine, and valine) supplemen-
tation has been demonstrated to enhance glycogen reserves in
trained rats, in rested state [8] and enhance mitochondrial
biogenesis [9].
The mixture of BCAAs comprises three of the nine essential
amino acids present in animal food sources (e.g., milk proteins).
Of the three BCAAs, isoleucine and valine are glucogenic, and
leucine is ketogenic [10]. More than 50% of BCAAs are catabolized
in muscle; in liver this capacity is relatively small [10,11].
Muscle is not a gluconeogenic tissue; therefore, if valine and
isoleucine are to be converted to glucose, they cannot be
completely oxidized in this tissue [12]. However leucine appears
to regulate oxidative use of glucose by skeletal muscle through
stimulation of glucose recycling via the glucose-alanine cycle
[13]. This occurs through the transamination process, which
involves the reversible transfer of the amino group to a-keto-
glutarate, generating glutamate, by the enzyme branched-chain
amino transferase. Glutamate is then transaminated by pyru-
vate amino transferase, which transfers the amino group from
glutamate to pyruvate generating alanine. Then, alanine is
metabolized out of muscle tissue (liver) to produce glucose
(Fig. 1) [11,12]. These mechanisms produce protein sparing and
provide a stable glucose environment with low insulin responses
during energy-restricted periods [14,15]. As an insulin secreta-
gogue, leucine can modulate glucose uptake through this
hormonal response; furthermore, leucine is strongly involved in
the protein translation initiation pathway, which is also relatedFig. 2. Experimental design of the study.with glucose homeostasis through Glut4 translocation to the
sarcolemma. Thus, leucine can modulate glucose metabolism
through insulin-dependent and insulin-independent pathways
[16] (Fig. 1).
During the ﬁrst minutes of exercise, there is an accumulation
of tricarboxylic acid cycle intermediates (TCAIs) in muscle, which
could be attributed to a few mechanisms, such as the reactions
catalized by alanine aminotransferase (ALT); the TCAIs that
augment the most during the ﬁrst minute of exercise are succi-
nate, fumarate, and malate ([17,18]. In prolonged exercise, the
main evidence supporting the hypothesis linking muscle TCAIs
pool alterations with glycogen utilization is that, in exhaustion,
TCAIs levels are lower than in the ﬁrst minutes of exercise [17,19].
In a deprived glycogen situation, in addition to a mixture of
BCAAs supplementation, it has been hypothesized that a-keto-
glutarate would be drained off tricarboxylic acids cycle to oxidize
BCAAs, which is named “the carbon drain hypothesis” [12]. Some
studies have demonstrated that muscle TCAIs pool is not
necessarily linked to aerobic energy provision mechanisms [17,
20]. However, to address this question, few studies focused on
performance during intense exercise on glycogen depletion
comparing leucine supplementation against a mixture of BCAAs
supplement in trained condition.
In a double-blind crossover design, our group recently
demonstrated that healthy humans supplemented with the
mixture of BCAAs (300 mg∙kg∙d1) for 3 d and submitted to an
exercise-induced glycogen depletion on day 2 of supplementation
presented a greater resistance to fatigue, reduced respiratory
exchange ratio (RER), and higher plasma glucose during an
exhaustive exercise test performed on the third [21]. However,
muscle measurements (i.e., enzymatic activity) and its relation
with exercise performance were not investigated [21]. One study
[7] supplemented BCAAs (both 300 and 450 mg∙kg∙d1)
in trained rats to investigate resistance to fatigue in animals
performing moderate exercise for more than 100 min. The
results found in this study indicate that the lower BCAAs dose
supplementation (BCAAs 300mg∙kg∙d1) improved performance
related to peripheral fatigue compared with control and
higher BCAAs supplementation groups. The latter (BCAAs 450
mg∙kg∙d1) featured an impaired resistance to fatigue compared
with the two other groups; however, this study did not verify
either TCAIs concentrations or liver enzymatic activity. Of note,
the animals in this study were not glycogen depleted before
exercise.
The present study aimed to evaluate effects of the use of
supplementation with leucine or a mixture of BCAAs in trained
rats submitted to an exercise-induced protocol of glycogen
depletion. Furthermore, we attempted to investigate muscle and
liver biochemical parameters that were not performed in the
previous study in order to elucidate the role of BCAAs in glycogen
depletion. Our hypothesis is that the mixture of BCAAs supple-
mentation would impair performance because they would be
used mostly in muscle to yield acetyl-CoA, reducing the activity
of the glucose-alanine cycle and thus gluconeogenesis in liver
from amino acids, whereas leucine alone could feature the
opposite effect in this experimental model.Materials and methods
Animals
The Ethics Committee of the Institute of BiologydState University of Cam-
pinas (UNICAMP) approved the Experimental Protocol. Twenty-four male Wistar
SPF rats (90 g), aged 4 wk, provided by the Central Biotery of the State University
of Campinas (CEMIB - UNICAMP, Campinas, Brazil) were kept in our facility until
Table 1
Swimming training protocol
Week of training Session
Adaptation 20 minutes, no load attached to the animal
1 20–25 min (5% BW load)
2 25–30 min (5% BW load)
3 35–40 min (5% BW load)
4 45–50 min (5% BW load)
5 55–60 min (5% BW load)
6 Lactate Threshold Test þ maintenance of training)
7 Supplementation þ maintenance of training)
8 Performance Test (8–10% BW load)
BW, body weight
P. L. Campos-Ferraz et al. / Nutrition 29 (2013) 1388–13941390they were 8 wk old (250 g, adult). They were housed (four animals per cage)
under controlled environmental conditions (22C, 12-h dark period starting at
0700) and fed with appropriate diet (NUVILAB CR1, NUVITAL, Curitiba, Brazil),
containing approximately 52% carbohydrates, 21% protein, and 24% lipids. Water
and food were provided freely. The animals were treated and exercised always in
the dark phase of the 12-h cycle, and infrared lights were used in the facility, so
that they would not be bothered by ultraviolet light.
Experimental design
Randomization
After the animals reached the age of 8 wk, they were randomly divided into
three experimental groups (n ¼ 8), as described in Figure 2.
Exercise training protocol
After randomization, they started the exercise program in a swimming
device specially designed for rats [22] as described in Table 1, always between
1400 and 1700. This training protocol was published previously [8]. After 6 wk of
training, the rats were able to swim for 1 h with a 5% of their body weight lead
load attached to their bodies, which corresponded to a moderate intensity
exercise [23]; afterward, a lactate threshold test was performed, as described
below, to establish the intensity of the ﬁnal sub maximal exercise test (Fig. 2).
Lactate threshold test
In order to precisely adjust the exercise intensity of the ﬁnal performance
experiment, after 6 wk of physical training, the rats were submitted to an
intermittent, progressive swimming test to determine lactate threshold in the
beginning of week 7 of the experiment (Fig. 2). This test consisted on determi-
nations of lactate blood, by punction of the tail vein, either before exercise, or
after a 3-min exercise bout with a determined lead load attached to its body
(Table 1), until exhaustion, which was deﬁned as a period of 10 sec without
emerging their noses out of the water. Tail-vein blood was collected by capil-
larity; NaF 2% solution was used to prevent coagulation, and the samples were
read immediately in a Yellow Springs Lactometer (ES 800). Blood lactate levels
were plotted into curves and lactate threshold was determined at their inﬂexion
points as described previously [24] (data not shown).
Supplementation protocol
One day after the lactate threshold test and still during week 7 of the
experiment, the supplementation protocol began. Animals were supplemented
orally by intragastric gavage throughout the following 7 d with either the
mixture of BCAAs, leucine, or placebo (Fig. 2), 166 mg of the corresponding amino
acids/kg daily diluted in 2 mL distilled water. This dose has been determined
based on the calculations of leucine ﬂux in humans as 88 mg/g daily [25] and
BCAAs oxidation as 144 mg/kg daily [26]. In order to make an isonitrogenous
supplementation between the LEU and BCAAs groups, the amount of 166 kg LEU/
kg, which corresponded to two times the determined LEU ﬂux dose, as described
above, was applied and equalized in the BCAAs group. All amino acids were
provided by Ajinomoto (Tokyo, Japan).
Liver glycogen depletion protocol
On day 6 of supplementation, rats were kept fasted after their swimming
session, until complete 24 h before the ﬁnal experiment, in order to deplete liver
glycogen. This protocol of glycogen depletion has been previously determined on
a pilot study from our group.Submaximal performance test
On day 7 of supplementation, and already on week 8 of the experiment
(Fig. 1), rats were submitted to a more intense swimming protocol [24]: They
swam gently for the ﬁrst 10 min, then a 7% or 8% of body weight lead load was
attached to their bodies, according to the animal’s lactate threshold test, until
they achieved two load level increments than its lactate curve’s inﬂection point,
previously determined by lactate threshold test to characterize a submaximal
exercise. They swam until exhaustion (deﬁned as the moment where the animal
was not able to maintain its nose nose out of water for more than 10 sec), when
they were sacriﬁced by decapitation. Muscles gastrocnemius and liver were
depicted and rapidly frozen in liquid nitrogen, until further analysis.
Muscle and liver glycogen concentration
Radioactive isotopes and all the enzymes were purchased from Sigma Co. (St.
Louis – MO). Kits for enzyme activity determinations, when used, were obtained
from Bioclin (QUIBASA, Belo Horizonte, Brazil). Muscle and liver glycogen were
determined according to the method described elsewhere [24]: 1-g piece of
frozen muscle was removed from each sample. Tissues were heated in 6N KOH
solution and then submitted to glycogen extraction with ethanol 70% solution.
Glycogen was then hydrolyzed to glucose with a sulfuric acid plus anthrone
solution, which produced a green color. Colorimetric determinations were made
at 650 nm, in a Perkin-Elmer Lambda 25 Spectrophotometer.
Muscle and liver glycogen degradation ratio
Muscle and liver glycogen degradation ratio were determined according to
a previous study [24] where tissue glycogen concentration (mg/100 mg wet
tissue) were plotted against time to fatigue (min) in the submaximal swimming
test described previously.
Muscle TCAIs
All muscle tissue preparation and TCAIs were performed according to
a previous study [27]. A 1-g piece of frozen muscle was removed from each
sample. The samples were diluted in 10 mL of 0.6 M perchloric acid buffer. They
were homogenated gently with a pestle. The homogenates were centrifuged at 10
000g, 10C, and a sonicator was used to improve tissue homogenization. Super-
natants were separated, neutralized with 60 mL TRIS/KOH buffer and 10mL of
Universal Indicator, so that a green color was formed. Homogenates were frozen
in liquid nitrogen until further analysis. They were assayed enzimatically for
a-keto glutarate, citrate, malate, 2-oxoglutarate, by spectrophotometry, and
fumarate was determined using a ﬂuorimetric assay (Hitachi F-2000 ﬂuores-
cence spectrophotometer, Hitachi Instruments, Japan) [17,27]. Gastrocnemius
muscle homogenate neutralized on basic pH (20 uL) was added to 160 uL
hydrazine hydrate buffer until the ﬁnal volume of 100 mL and maintained in
freezer. Additionally, 20 mL EDTA were added (0,1 mol/L) and 20 uL reduced
acetyl-pyridine-adenine-dinucleotide (0,1 mol/L). The samples were analyzed in
the primary wavelength of 360 nm and secondary wavelength of 440 nm.
Afterward, malate dehydrogenase (MDH) (EC 1.1.1.37) was added (500 U) in
a ﬁnal concentration of 1uL MDH to 5mL TRIS buffer (0.02 mol/L) plus 0.02%
bovine serum albumin to determine malate concentration. A 20-min pause was
performed until the next analysis in room temperature. Then fumarase (EC
4.2.1.2) was added (1 kU/L) in a concentration on 10 uL enzyme to 9.990 mL TRIS
buffer (0.02 mol/L), to determine fumarate levels. Another 20-min pause was
performed before the second ﬂuorimetric analysis in room temperature. Stan-
dard curve was made with fumarate standard solution (1 mol/L) and a solution of
perchloric acid, KHCO3 and distilled water was used as a blank.
Enzymes activity
Maximum citrate synthase activity (EC 4.1.3.7) was determined as described
previously [28]. which is based on reaction between oxaloacetate and acetyl-CoA,
forming citrate and CoA. Dithiobenzoic acid (DTNB), when reacting with CoA,
yields a yellow-colored complex whose formation is proportional to the
enzyme’s activity. Tissues were added to a TRIS-HCl 50 mM buffer and EDTA1
mM, pH 7.4. Assay buffer was the following: TRIS-HCl 100 mM, DTNB 0.4 mM,
TRITON X-100 0.05%, and acetyl-CoA 15 mM; the substrate added was oxaloac-
etate 1 mM and the ﬁnal volume was set to 950 uL. After the addition of the
substrate, DTNB-CoA was determined in the following 10 min in room temper-
ature by spectrophotometry at 412 nm.
ALT (EC 2.6.1.2) and aspartate aminotransferase (AST) (EC 2.6.1.1) concen-
trations were essayed with kinetic test kits usually used in clinical laboratories in
Brazil (Bioclin, QUIBASA, Belo Horizonte, Brazil) according to Bergmeyer modi-
ﬁed [29]. Basically, ASTcatalyzes the transfer of amine groups to a-keto-glutarate,
forming both glutamate and oxaloacetate. The latter reacts with nicotinamide
adenine dinucleotide hydrogen (NADH), in the presence of MDH, formingmalate,
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Fig. 3. Live glycogen degradation (A); liver glycogen content (B); muscle glycogen degradation (C); muscle glycogen content (D) in placebo (PLA), the mixture of BCAAs, and
leucine (LEU) groups. Data are expressed as mean  SD. * P < 0.05 versus PLA group; y P < 0.05 versus the mixture of BCAAs group.
P. L. Campos-Ferraz et al. / Nutrition 29 (2013) 1388–1394 1391and NADH is oxidized to NADþ. ALT catalyzes the transfer of alanine amine group
to a-keto-glutarate, forming pyruvate and glutamate. Pyruvate, in the presence of
lactate dehydrogenase, reacts with NADH, forming lactate and NADH oxidizes to
NADþ. The speed of these two reactions is measured in spectrophotometer at
340 nm and is proportional to AST and ALT activity in the samples, respectively.
Branched-chain transaminase (BCAT) (EC 2.6.1.42) was isotopically assayed
as described previously [30], modiﬁed. The assay was performed at 37C and the
ﬁnal volume was set to 400 uL; the assay medium contained 154 mM manitol,
49 mM sucrose, 78 mM HEPES buffer, pH 7.4 at 37C, 25 mM potassium dihy-
drogen phosphate, 8 mM sodium carbonate, 2 mMMgCl2, 1.1 mM EGTA. Nonidet
P-40, pyridoxal 5-phosphate, and a-keto-glutarate were present in the medium
up to the concentration of 5 g/L, 0.1 mM, and 5 mM, respectively. The amount of
enzyme and the activity were linearly correlated. After 5 min pre-incubation, 100
uL of each fraction, l-[l-14C]leucine (30 desintegrations/min or dpm) per umoL
was added to the essay medium up to the ﬁnal concentration of 8 mM. Reaction
was interrupted with 0.1 mL 4M sulphuric acid. 0.5 mL of 0.2M ceric sulphate in
2 M H2SO4 was used to decarboxylate alphaketo[l-14C]isocaproate produced
during the incubation. All assays were run in duplicate and they featured linear
correlation with time and amount of enzyme. Radioactive carbon dioxide was
collected in 1 mL methylcellosolve-ethanolamine mixture (2:1, v/v) and deter-
mined by liquid scintillation.
Statistical analysis
Values are presented as means  SD. Statistical evaluationwas performed by
one-way ANOVA to analyze the effects of supplementation type. When a signif-
icant overall effect was detected, differences among statistical means were
assessed with Tukey post hoc test. The level of signiﬁcance was set at P< 0.05 for
all statistical tests. All statistical analysis were performed using the software SPSS
20.0 for Windows(IBM SPSS Statistics version 17.0 for Windows, Somers , NY).
Results
Our data demonstrated that liver glycogen degradation ratio
was signiﬁcantly higher in themixture of BCAAs group compared
with the PLA group (Fig. 3A; PLA 3.6  2.5 mg/100 mg/min versus
the mixture of BCAAs 54.9  28.8 mg/100 mg/min; P < 0.001).
However, the LEU group presented decreased liver glycogen
degradation ratio when compared to themixture of BCAAs group
(Fig. 3A; LEU 25.8  11.4 mg/100 mg/min versus the mixture of
BCAAs group; P < 0.05). Liver glycogen content was signiﬁcantly
spared in themixtureofBCAAsandLEUgroupscomparedwith thePLA group (Fig. 3B; The mixture of BCAAs 0.19  0.10 mg/100 mg
versus PLA 0.02  0.17 mg/100 mg/min; P <0.05; LEU 0.23 
0.09 mg/100 mg versus PLA group; P < 0.01).
The muscle glycogen degradation ratio was signiﬁcantly
suppressed in the LEU group compared with both PLA and the
mixture of BCAAs groups (Fig. 3C; LEU 7.9  3.2 mg/100 mg/min
versus PLA 23.61  4.6 mg/100 mg/min; P < 0.05; LEU group
versus the mixture of BCAAs 29.07  5.16 mg/100 mg/min, P <
0.01). However, muscle glycogen content was signiﬁcantly
reduced in the LEU group compared with the PLA group (Fig. 3D;
LEU 0.08  0.02 mg/100 mg versus PLA 0.18  0.03 mg/100 mg;
P < 0.05). In the mixture of BCAAs group, muscle glycogen did
not differ compared with the others (Fig. 3D; the mixture of
BCAAs 0.11  0.02 mg/100 mg; P > 0.05).
Muscle citrate content was signiﬁcantly higher in the mixture
of BCAAs group compared with the PLA group (Fig. 4A; the
mixture of BCAAs 9.8  1.0 mmol/mg versus PLA 3.5  0.6 mmol/
mg; P < 0.001). Fumarate, oxaloacetate, and 2-oxo-glutarate
content in muscle did not differ among groups (Fig. 4A; P> 0.05).
Muscle malate content was signiﬁcantly elevated in the mixture
of BCAAs group compared with both the PLA (Fig. 4A; the
mixture of BCAAs 648.1  59.5 mmol/mg versus PLA 292.7  46.0
mmol/mg; P < 0.001) and LEU groups (Fig. 4A; the mixture of
BCAAs group versus LEU 317.4  43.0 mmol/mg; P < 0.001).
Use ofmuscle citratewas signiﬁcantly increased in themixture
of BCAAs group compared with both the PLA and LEU groups
(Fig. 4B; themixture of BCAAs 0.52 0.13 nmolmgmin1 versus
PLA 0.08  0.03 nmolmgmin1 and LEU 0.09  0.05
nmolmgmin1; P < 0.01). This same result pattern was
observed in a-keto-glutarate (Fig. 4C; the mixture of BCAAs
0.09  0.03 nmolmgmin1 versus PLA 0.01  0.003
nmolmgmin1 and LEU 0.009  0.005 nmolmgmin1;
P < 0.05) and malate utilization (Fig. 4E; the mixture of BCAAs 12
415  2879 nmolmgmin1 versus PLA 4076  865.1
nmolmgmin1 and LEU 25851079 nmolmgmin1; P< 0.05
and P < 0.01, respectively). Oxaloacetate utilization was statisti-
cally different in themixture of BCAAs group onlywhen compared
020
40
60
400
800
Citrate
2-oxo-glutarate
Fumarate
Malate
Oxaloacetate
PLA LEU
*,†
*,†
A
M
u
s
c
le
 
[
 
]
 
o
f
 
T
C
A
 
In
t
e
r
m
e
d
ia
t
e
s
(
µ m
o
l/
m
g
)
PLA LEU
0.0
0.2
0.4
0.6
0.8
B
‡, §
C
it
r
a
t
e
 
u
t
il
iz
a
t
io
n
(
µg
/
1
0
0
m
g
/
m
i
n
)
PLA LEU
0.00
0.05
0.10
0.15
C
*
†
-
k
e
t
o
-
g
l
u
t
a
r
a
t
e
 
u
t
i
l
i
z
a
t
i
o
n
(
µg
/
1
0
0
m
g
/
m
i
n
)
PLA LEU
0
500
1000
1500
2000
2500
D
F
u
m
a
r
a
t
e
 
u
t
il
iz
a
t
io
n
(
µg
/
1
0
0
m
g
/
m
i
n
)
PLA LEU
0
5000
10000
15000
20000
E
*, †
M
a
la
t
e
 
u
t
il
iz
a
t
io
n
(
µg
/
1
0
0
m
g
/
m
i
n
)
PLA LEU
0.0
0.2
0.4
0.6
0.8
1.0
F
*
O
x
a
lo
a
c
e
t
a
t
e
 
u
t
il
iz
a
t
io
n
(
µg
/
1
0
0
m
g
/
m
i
n
)
0
50
100
150
200
250
Citrate Synthase (µmol/min/mg)
ALT (U/mg)
AST (U/mg)
BCAT (nmol/min/g)
PLA LEU
*,†
G
E
n
z
y
m
e
s
' 
a
c
t
iv
it
y
/
c
o
n
c
e
n
t
r
a
t
io
n
BCAAs
BCAAs
BCAAs
BCAAs
BCAAs
BCAAsBCAAs
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P. L. Campos-Ferraz et al. / Nutrition 29 (2013) 1388–13941392with the PLA group (Fig. 4F; the mixture of BCAAs 0.60  0.19
nmolmgmin1 versus PLA 0.06  0.01 nmolmgmin1; P <
0.05). Fumarate utilization was not signiﬁcantly different among
the three groups (Fig. 4D; P > 0.05).
Muscle citrate synthase (EC 4.1.3.7) activity, AST (EC 2.6.1.1),
and ALT (EC 2.6.1.2) concentration did not differ among groups
(Fig. 4G; P > 0.05). However, the mixture of BCAAs supplemen-
tation signiﬁcantly decreased branched-chain amino acids
transaminase (EC 2.1.6.42) activity when compared with both
PLA (Fig. 4G; the mixture of BCAAs 28.0  4.0 nmolmgmin1
versus PLA 39.7  6.0, nmolmgmin1; P < 0.001) and the LEU
group (Fig. 4B; the mixture of BCAAs group 28.0 4.0 versus LEU
40.0  3.0 nmolmgmin1; P < 0.001).
The performance test demonstrated that LEU supplemen-
tation enhanced resistance to exhaustion when compared with
the mixture of BCAAs (Fig. 5; LEU 9.4  0.9 min versus thePLA LEU
0
5
10
15
*
†
R
e
s
is
t
a
n
c
e
 
t
o
 
f
a
t
ig
u
e
(
m
in
)
BCAAs
Fig. 5. Performance test of time to exhaustion in placebo (PLA), the mixture of
BCAAs, and leucine (LEU) groups. Data are expressed as mean  SD. * P < 0.05
versus PLA group; y P < 0.05 versus the mixture of BCAAs group.mixture of BCAAs 3.6  0.1 min; P < 0.001), however, no
difference was found when LEU supplementation was
compared with PLA (Fig. 5; LEU 9.4  0.9 min versus PLA 8.4 
1.2 min; P > 0.05).Discussion
To our knowledge, this is one of the few studies comparing
the mixture of BCAAs effects against leucine supplementation in
low-carbohydrate availability, and one of the few showing that
leucine alone can prevent impaired endurance exercise perfor-
mance compared with the mixture of BCAAs in glycogen
depletion.
As stated previously, liver glycogen is fundamental to glucose
homeostasis [31]. In our results, leucine supplementation had no
improving effect on absolute liver glycogen content compared
with the mixture of BCAAs or placebo, as expected, because all
the animals were fasted and exhausted. However, we observed
that leucine supplementation decreased both liver and muscle
glycogen degradation and improved performance. The hepatic
glycogen in the leucine group data is in accordance with other
studies indicating that supplementation of some amino acids
preserves liver glycogen [6,7,24]. The following results lead to the
initial hypothesis that the main effect of leucine is improving
muscle glucose availability because leucine has important effects
to glucose homeostasis [14]. According to a previous study [13],
increased serum leucine concentration and its metabolite
alpha-ketoisocaproate (a-KIC) inhibit branched-chain keto acids
dehydrogenase complex (BCKD) kinase and hence stimulate
BCKD dephosphorylation (activation), enhancing the oxidation
of other essential amino acids (e.g., isoleucine and valine), which
could contribute indirectly to muscle and liver glycogen sparing.
Also, amino acids act as primary sources of carbon for hepatic
gluconeogenesis [32] and when intracellular levels of leucine
are elevated, a decrease in pyruvate dehydrogenase (PHD)
Fig. 6. Increased leucine availability to the muscle implies in a lower Pyruvate
Dehydrogenase activity in muscle and an augmented concentration of alanine,
which goes to the bloodstream and reaches the liver, making it possible to generate
more glucose through glucose-alanine cycle. Also, leucine increases BCKD activity
in this tissue, elevating isoleucine and valine oxidation in liver, which can also serve
as carbon donors for glucose synthesis when energy supply is low.
P. L. Campos-Ferraz et al. / Nutrition 29 (2013) 1388–1394 1393activity is observed; muscle uses glucose originated from either
the blood or glycogen stores, trapping pyruvate carbon as
alanine, via transamination with amino groups derived from
BCAAs, especially in a situation where cell energy supply is low,
as low insulin levels and sparing blood glucose become impor-
tant (Fig. 6) [12,14,33].
This mechanism was also described in a previous study [34]
and showed that factors such as high-protein diets, and cata-
bolic situations such as fasting, diabetes, sepsis, cancer, and
cytokines also can contribute to such regulation: Basically, rats
fed with low-protein diets feature reduction of BCKD complex
activity, however it increases in starvation, diabetes, sepsis, and
other conditions trough up regulation of branched-chain kinase
expression, which in turn inactivates BCKD and spares BCAAs for
protein synthesis [35].
In our study, muscle malate and citrate concentrations were
augmented in the mixture of BCAAs group, and the same
occurred for malate and citrate. In branched-chain amino acid
transaminase (BCAAT) knockout mice, the disruption of BCAAs
metabolism impaired malate-aspartate shuttle, resulting in
decreased alanine/glutamine formation [36]. In line with this,
the observations above indicate that the mixture of BCAAs
supplementation in glycogen depletion and intense exercise
increased TCAIs availability for the left side of the TCA cycle,
which constitutes 80% of the muscle TCAIs pool during exercise
[17]. Also, muscle a-keto glutarate utilization was increased in
the mixture of BCAAs group compared with the PLA and LEU
groups. This is in accordance with the hypothesis of the carbon
drain [37].
This result was reﬂected in the exercise performance test,
which demonstrated that leucine supplementation prevented
a decrease in time to exhaustion compared with the mixture of
BCAAs supplemented group, possibly due to glycogen sparing.
This is in contrast with the results of previous experiments
performed by our group with humans [21], where the mixture of
BCAAs supplementation improved performance. At this point, it
is important to note that liver BCKD activity in humans and in
rats is quite different: In the latter, liver BCKD is almost
completely unphosphorylated (activated) in basal state, making
it possible to metabolize more rapidly BCKA from the portalblood; in humans, BCKD in liver is normally phosphorylated
(inactivated) in order to spare BCAAs for protein synthesis [34].
Thus, liver BCKD in rats is more active with physical exer-
cise since it is known that endurance training raises BCKD
activity in liver [38] through BCKD kinase inhibition [39]. This
phosphorylation state can be crucial in the use of amino acids
to both tissue protein synthesis, attenuation of protein
degradation, and also mobilization as energy source [34,40,41].
In this way, we believe that these differences in liver BCKD
activity between humans and rats can explain the distinct
results in our studies because the mixture of BCAAs supple-
mentation in humans would not stimulate BCKD complex
activity as it does in rats [42].
In a study performed with carnivore ﬁshes (Sparus aurata)
supplementedwith an inhibitor of liver ALT, it was found that the
diet carbohydrate utilization was increased, and simultaneously,
alanine utilization as a glucose precursor in liver was impaired
[43] irrespective of the diet; in another experiment, rats sup-
plemented with carbohydrate plus leucine, compared with
carbohydrate alone, had increased muscle glucose uptake and
cellular signaling with a lower insulin response [44]. Conversely,
another study [45] found that rats consuming a high-protein and
low-carbohydrate diet featured a greater muscle metabolism
signaling compared with a normal diet, although no relation to
leucine or BCAAs content of the diet was established. Consid-
ering all this data, we suggest that enhancing the glucose alanine
cycle in liver through leucine supplementation might have an
interesting use in physical performance in prolonged or
submaximal exercise, where muscle glycogen stores are more
likely to be depleted.
Conclusion
In conclusion, in the present experimental conditions, the
mixture of BCAAs and LEU supplementation in glycogen-depleted
rats and before intense physical activity featured distinct effects
on performance: LEU supplementation improved performance
compared with the mixture of BCAAs supplementation, sparing
muscle glycogen stores. Taken together, these data suggest that
in the mixture of BCAAs group, glycogen depletion occurred
faster than in the LEU group, despite the augmentation of some
TCAIs concentrations on the left side of the cycle. Although we
have not estimated other direct measures as glucokinase and/or
PDH activity, or GLUT-4 expression, our results are in accor-
dancewith another study [46] inwhich rats supplemented with
the mixture of BCAAs featured accelerated glucose utilization
and glucose-6-P in the liver, probably due to transcriptional
mechanisms. Future studies should evaluate other enzymes and
post-translational proteins enrolled in the mixture of BCAAs
and glucose oxidation such as glucokinase and/or PDH, and
GLUT-4.
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